Based on the provided data and recent market activity, here's a concise analysis of CDW stock:
Technical Analysis
The stock is currently trading at $186.93 during regular market hours on Monday, showing a modest gain of +0.23% [Relevant Data]. Key technical levels:
- Support: $183.81 (Fibonacci S2)
- Resistance: $197.78 (Fibonacci R1)
- Current RSI (14): 43.24 indicates neutral territory
- MACD shows bearish divergence with -1.21 histogram
Recent Performance & Events
- Q4 2024 Results:
- Net sales: $5.186 billion (+3.3% YoY)
- Corporate segment: $2.35 billion (+4.2% YoY)
- Healthcare customer sales: +29.5% growth
- Adjusted EPS: $2.48 (beat consensus of $2.32)
Corporate Actions
Two significant announcements on February 5, 2025:
- $750 million increase to share repurchase program
- Quarterly dividend increase to $0.625 per share (+1% YoY)
Management Outlook
CEO Christine A. Leahy stated: "For 2025, we continue to target exceeding US IT market growth by 200 to 300 basis points" through:
- Focus on serving 250,000+ global customers
- Maintaining partnerships with 1,000+ technology brands
- Emphasis on AI solutions integration
Upcoming Event
CDW's CFO Albert J. Miralles will present at the Morgan Stanley Technology Conference on March 4, 2025, which could provide additional insights into company strategy.
Recommendation
SELL - Based on:
- Technical indicators showing bearish momentum
- Stock trading below key Fibonacci pivot point of $192.45
- RSI indicating potential downside risk
- Recent price action showing resistance at higher levels